NEW YORK (GenomeWeb News) – Shimadzu today announced the creation of a wholly owned subsidiary in Uruguay to bolster its Central and South American business.

Shimadzu Latin America (SLA) will serve as Shimadzu's base in the region. Shimadzu do Brasil Comercio (SBL) in Sao Paulo was created in 1997 and had been coordinating Shimadzu's operations in Central and South America. As SBL's business within Brazil grew and Brazilian regulations limited SBL's trading activities with its neighbors, Shimadzu chose to create SLA, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.